Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Heron Therapeutics (HRTX) Asset Utilization Ratio (2016 - 2026)

Heron Therapeutics filings provide 13 years of Asset Utilization Ratio readings, the most recent being 0.6 for Q1 2026.

  • On a quarterly basis, Asset Utilization Ratio fell 5.23% to 0.6 in Q1 2026 year-over-year; TTM through Mar 2026 was 0.6, a 5.23% decrease, with the full-year FY2025 number at 0.63, changed 0.03% from a year prior.
  • Asset Utilization Ratio hit 0.6 in Q1 2026 for Heron Therapeutics, down from 0.61 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.64 in Q3 2025 to a low of 0.31 in Q1 2022.
  • Median Asset Utilization Ratio over the past 5 years was 0.6 (2024), compared with a mean of 0.55.
  • Biggest five-year swings in Asset Utilization Ratio: surged 67.06% in 2022 and later dropped 5.23% in 2026.
  • Heron Therapeutics' Asset Utilization Ratio stood at 0.41 in 2022, then soared by 36.59% to 0.56 in 2023, then increased by 13.02% to 0.64 in 2024, then decreased by 3.47% to 0.61 in 2025, then dropped by 2.18% to 0.6 in 2026.
  • The last three reported values for Asset Utilization Ratio were 0.6 (Q1 2026), 0.61 (Q4 2025), and 0.64 (Q3 2025) per Business Quant data.